Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RSV Immunisation”

64 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 64 results

Post-approval studies (Phase 4)Active Not RecruitingNCT06551506
What this trial is testing

The Immunology and Safety of Maternal RSV Vaccination (ABRYSVO), Infant Nirsevimab (BEYFORTUS) Immunization, or Both Products

Who this might be right for
Respiratory Syncytial Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 181
Not applicableStudy completedNCT06185647
What this trial is testing

Evaluation in Practice of the Impact of NIrsevimab on EmeRgency Use for BRONCHIOlitis

Who this might be right for
BronchiolitisRespiratory Syncytial Virus (RSV)Immunization; Infection
Hôpital Armand Trousseau 4,924
Not applicableStudy completedNCT02273882
What this trial is testing

An Observational Study of Respiratory Syncytial Virus (RSV) Hospitalizations in Preterm Infants

Who this might be right for
Respiratory Syncytial Virus Hospitalizations
AstraZeneca 497
Not applicableLooking for participantsNCT06180993
What this trial is testing

Evaluation of the Effectiveness and Impact of Nirsevimab Administered as Routine Immunization

Who this might be right for
RSV Infection
Federico Martinón Torres 42,000
Not applicableStudy completedNCT02282982
What this trial is testing

Observational Program to Assess Respiratory Syncytial Virus (RSV) Hospitalization Rate in Population of Children at High-risk of Serious RSV Illness Who Received Palivizumab Immunoprophylaxis

Who this might be right for
Respiratory Syncytial Virus (RSV)
AbbVie 359
Not applicableActive Not RecruitingNCT06993753
What this trial is testing

Duration of Protection of Nirsevimab Against Hospitalisation for Respiratory Syncytial Virus Infection

Who this might be right for
Respiratory Syncytial Viral (RSV) Infections
Griffith University 4,350
Not applicableActive Not RecruitingNCT07122661
What this trial is testing

STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON)

Who this might be right for
Respiratory Syncytial Virus (RSV)Respiratory Syncytial VirusLower Respiratory Tract Disease+2 more
Pfizer 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT06686654
What this trial is testing

Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older

Who this might be right for
Human Metapneumovirus ImmunizationRespiratory Syncytial Virus Immunization
Sanofi Pasteur, a Sanofi Company 1,530
Testing effectiveness (Phase 2)Study completedNCT03334695
What this trial is testing

An Exploratory Study to Evaluate the Prophylactic Efficacy of a Single Immunization of Ad26.RSV.preF Against Respiratory Syncytial Virus Infection in a Virus Challenge Model in Healthy 18 to 50 Year-old Adults

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 64
Large-scale testing (Phase 3)Looking for participantsNCT06866405
What this trial is testing

Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose

Who this might be right for
RSV Infection
Pfizer 550
Testing effectiveness (Phase 2)Looking for participantsNCT07050732
What this trial is testing

Immunogenicity of RSVPreF3 Vaccine in Immunocompromised Persons

Who this might be right for
Respiratory Syncytial Virus (RSV)
Johns Hopkins University 170
Large-scale testing (Phase 3)Ended earlyNCT06705140
What this trial is testing

A Study on the Immunogenicity and Safety of 3 Different Dose Concentrations of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Who this might be right for
RSV Immunisation
Sanofi Pasteur, a Sanofi Company 947
Not applicableLooking for participantsNCT06259487
What this trial is testing

Coordinated Vaccination Against RSV and Influenza in Patients With Chronic Heart Failure and Its Impact on Prognosis.

Who this might be right for
Heart FailureRSV InfectionInfluenza+1 more
Wroclaw Medical University 250
Post-approval studies (Phase 4)Looking for participantsNCT07097012
What this trial is testing

Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy

Who this might be right for
RSVTdap - Tetanus, Diphtheria and Acellular Pertussis VaccinationPregnancy+1 more
Canadian Immunization Research Network 60
Large-scale testing (Phase 3)Ended earlyNCT06397768
What this trial is testing

Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Who this might be right for
RSV Immunization
Sanofi Pasteur, a Sanofi Company 2,226
Post-approval studies (Phase 4)Not Yet RecruitingNCT06955728
What this trial is testing

A Clinical Trial on Safety in Pregnant Women and How Well the Infant is Protected Against RSV-associated Lower Respiratory Tract Infection When the Pregnant Woman Receives the Approved RSV Vaccine Compared to a Placebo.

Who this might be right for
RSV InfectionsRSV ImmunisationPreterm Labour
University of Witwatersrand, South Africa 13,000
Not applicableActive Not RecruitingNCT06824207
What this trial is testing

Repeated Cross Sectional Surveillance Study To Determine the Respiratory Syncytial Virus (RSV) Immunization Rates in German Infants

Who this might be right for
Respiratory Syncytial Virus Immunization
Sanofi Pasteur, a Sanofi Company 2,400
Early research (Phase 1)Study completedNCT06850051
What this trial is testing

A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age.

Who this might be right for
Healthy VolunteersInfluenza VaccinationRespiratory Syncytial Virus Vaccination+2 more
Sanofi 270
Large-scale testing (Phase 3)WithdrawnNCT05229068
What this trial is testing

Safety, Reactogenicity and Immune Response of the Repeat Vaccination Against RSV When Given to Female Participants of 18-49 Years of Age During Their Subsequent Uncomplicated Pregnancy

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline
Not applicableStudy completedNCT03614676
What this trial is testing

Outcomes and Events of Interest in Pregnant Women, Neonates and Infants and of RSV Surveillance

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 4,493
Load More Results